Skip to main content
. 2022 Feb 21;10:815596. doi: 10.3389/fcell.2022.815596

FIGURE 3.

FIGURE 3

Expression of tumor antigens is associated with a variety of immune pathways and cell cycle pathways (A–B) Patients with high expression of KLRG1 and CBFA2T3 have more active immune-related pathways. (C–D) Patients with low expression of KLRG1 and CBFA2T3 have a more active cell cycle.